TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A new VA policy for younger veterans requires signed consent and documented discussion of antidepressant risks and benefits before prescribing. Separate studies report that an investigational smartphone app reduced negative symptoms in schizophrenia and that cutting ultraprocessed foods was associated with lower depression and anxiety scores in a small trial. The source summary does not provide the studies’ detailed results or the policy’s age cutoff and start date.
A new Veterans Affairs policy for younger veterans will require signed consent forms and documented conversations about antidepressant risks and benefits before a prescription is issued, according to a September 30 psychiatry news roundup citing The New York Times. The roundup also highlighted two separate research findings: an investigational app reduced negative symptoms in a randomized schizophrenia trial, while a small pilot trial linked reduced ultraprocessed-food intake with lower depression and anxiety scores.
The VA rule calls for clinicians to document that risks and benefits were discussed and to obtain a signed consent form before prescribing antidepressants to younger veterans. The supplied report does not specify which ages are covered, when the requirement takes effect, which antidepressants fall under it, or whether exceptions are allowed. Those details matter for veterans and clinicians trying to understand how the policy will affect care.
In a randomized trial reported in JAMA Network Open, an investigational smartphone app reduced the severity of negative symptoms in people with schizophrenia, according to the roundup. Negative symptoms can include reduced motivation or social engagement, but the summary provides no numerical effect size, trial length, participant count, or information about the app’s features. The result is a research finding, not evidence that the app is approved or available as routine treatment.
A small pilot crossover trial reported in JAMA Psychiatry found lower depression and anxiety scores among people with major depressive disorder when they reduced the amount of ultraprocessed food in their diets. A crossover design means participants receive more than one study condition, but the supplied account gives no sample size, duration, score changes, or details about how food intake was measured. The finding does not establish that dietary change alone treats depression.
Changes in Treatment and Evidence
The VA policy could change what younger veterans are asked to review and sign before starting an antidepressant, placing documented risk-benefit discussion at the center of prescribing. Its practical effect will depend on the age range, implementation date, and any clinical exceptions, none of which are included in the report summary. The policy concerns how treatment is prescribed; it does not, on the available information, indicate that antidepressants are being withdrawn or that a particular medicine is unsafe for every patient.
The app and diet findings point to areas researchers are testing alongside established mental-health care. A digital tool that reduces schizophrenia’s negative symptoms could merit further study, while the pilot diet result may help shape larger trials. But both reports are limited by missing details in the roundup, and neither supports replacing individualized clinical care. For patients, the distinction between an early research signal and a proven, accessible treatment is important.
antidepressant risk benefit discussion forms
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Three Separate Psychiatry Developments
The September 30, 2026, MedpageToday item is a brief psychiatry news roundup, not a single study or a detailed account of the VA policy. It draws on reporting and research from several outlets, including The New York Times for the policy and JAMA Network Open and JAMA Psychiatry for the study findings. The three developments concern different populations and questions: antidepressant prescribing for younger veterans, symptoms of schizophrenia, and diet among people with major depressive disorder.
The roundup also placed these items among reports on suicide, psychosis care, and other psychiatric research. It cited CDC figures indicating about 49,000 U.S. suicide deaths in 2023, compared with about 23,000 homicide deaths that year. That broader coverage does not establish a connection between those figures and the VA policy or either trial. The policy and studies should be understood as distinct developments, each requiring its own follow-up reporting and assessment.
schizophrenia symptom tracking app
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Policy and Trial Details Missing
The available account leaves key questions unanswered. It does not give the VA policy’s age cutoff, effective date, clinical exceptions, or enforcement process, nor does it reproduce the agency’s explanation for the requirement. The report attributes the policy information to The New York Times but supplies no direct statement from VA officials or clinicians affected by the rule.
For the app and diet research, the summary omits participant numbers, study duration, measured effect sizes, and follow-up results. It also does not say whether the app was compared with usual care or another intervention, or how much participants changed their ultraprocessed-food intake. Without those details, readers cannot judge how large or durable the reported effects were. The roundup reports an association between food reduction and improved scores in a pilot trial; it does not establish cause or generalize the result to everyone with depression.
As an affiliate, we earn on qualifying purchases.
Watch for Implementation and Replication
For the VA development, the next useful information will be the agency’s full policy language, including who is covered, when it starts, and how consent is recorded. Veterans and prescribers will need those details to understand how the requirement fits into clinical visits and existing care plans.
For the research, follow-up reporting should clarify the app trial’s size, results, and plans for further testing, as well as whether the tool will undergo any regulatory review. The diet finding needs larger and longer studies to test whether reduced ultraprocessed-food intake produces lasting changes in depression or anxiety scores. Until those details emerge, the reported findings remain preliminary and separate from the VA policy.
ultraprocessed food reduction cookbook
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What does the new VA antidepressant policy require?
According to the September 30 roundup, younger veterans must sign a consent form and have a documented discussion of antidepressant risks and benefits before receiving a prescription. The summary does not identify the age cutoff or start date.
Does the policy mean younger veterans cannot receive antidepressants?
No such restriction is described in the supplied report. It says the policy requires consent and documented discussion before prescribing; it does not say antidepressants are prohibited.
Is the schizophrenia app available as a treatment?
The roundup describes it as an investigational app tested in a randomized trial. It does not say the app is approved or available for routine clinical use.
Does the diet study show that avoiding ultraprocessed foods treats depression?
No. The small pilot crossover trial reported lower depression and anxiety scores when participants reduced ultraprocessed foods, but the summary does not provide enough detail to establish a lasting effect or show that diet alone treats depression.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
